Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 103 | |
10 mg | In stock | $ 185 | |
20 mg | In stock | $ 296 | |
50 mg | In stock | $ 578 | |
100 mg | In stock | $ 890 |
Description | Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. |
Targets&IC50 | HMG-CoA:11 nM |
Synonyms | ZD 4522 |
CAS No. | 287714-41-4 |
Chemical Formula | C22H28FN3O6S |
Molecular Weight | 481.54 |
Solubility | H2O: 199.4 mM DMSO: 199.4 mM |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom